Department of Clinical Neurosciences, Stroke Research Group, University of Cambridge, Cambridge, United Kingdom.
Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.
PLoS One. 2019 Oct 9;14(10):e0223246. doi: 10.1371/journal.pone.0223246. eCollection 2019.
Previous studies of radiological damage in rheumatoid arthritis (RA) have used candidate-gene approaches, or evaluated single genome-wide association studies (GWAS). We undertook the first meta-analysis of GWAS of RA radiological damage to: (1) identify novel genetic loci for this trait; and (2) test previously validated variants.
Seven GWAS (2,775 RA cases, of a range of ancestries) were combined in a meta-analysis. Radiological damage was assessed using modified Larsen scores, Sharp van Der Heijde scores, and erosive status. Single nucleotide polymophsim (SNP) associations with radiological damage were tested at a single time-point using regression models. Primary analyses included age and disease duration as covariates. Secondary analyses also included rheumatoid factor (RF). Meta-analyses were undertaken in trans-ethnic and European-only cases.
In the trans-ethnic primary meta-analysis, one SNP (rs112112734) in close proximity to HLA-DRB1, and strong linkage disequilibrium with the shared-epitope, attained genome-wide significance (P = 4.2x10-8). In the secondary analysis (adjusting for RF) the association was less significant (P = 1.7x10-6). In both trans-ethnic primary and secondary meta-analyses 14 regions contained SNPs with associations reaching P<5x10-6; in the European primary and secondary analyses 13 and 10 regions contained SNPs reaching P<5x10-6, respectively. Of the previously validated SNPs for radiological progression, only rs660895 (tagging HLA-DRB1*04:01) attained significance (P = 1.6x10-5) and had a consistent direction of effect across GWAS.
Our meta-analysis confirms the known association between the HLA-DRB1 shared epitope and RA radiological damage. The lack of replication of previously validated non-HLA markers highlights a requirement for further research to deliver clinically-useful prognostic genetic markers.
先前关于类风湿关节炎(RA)放射学损伤的研究采用了候选基因方法,或评估了单个全基因组关联研究(GWAS)。我们首次对 RA 放射学损伤的 GWAS 进行了荟萃分析:(1)确定该特征的新遗传位点;(2)测试以前验证的变体。
将七个 GWAS(2775 例不同种族的 RA 病例)合并进行荟萃分析。使用改良的 Larsen 评分、Sharp van Der Heijde 评分和侵蚀状态评估放射学损伤。使用回归模型在单个时间点测试与放射学损伤相关的单核苷酸多态性(SNP)关联。主要分析包括年龄和疾病持续时间作为协变量。二次分析还包括类风湿因子(RF)。在跨种族和仅欧洲人群中进行荟萃分析。
在跨种族的主要荟萃分析中,一个位于 HLA-DRB1 附近且与共享表位强连锁不平衡的 SNP(rs112112734)达到了全基因组显着性(P = 4.2x10-8)。在二次分析(调整 RF)中,相关性不那么显着(P = 1.7x10-6)。在跨种族的主要和次要荟萃分析中,14 个区域包含达到 P<5x10-6 的 SNP 关联;在欧洲的主要和次要分析中,13 个和 10 个区域分别包含达到 P<5x10-6 的 SNP 关联。在先前验证的放射学进展的 SNP 中,只有 rs660895(标记 HLA-DRB1*04:01)达到显着性(P = 1.6x10-5),并且在 GWAS 中具有一致的效应方向。
我们的荟萃分析证实了 HLA-DRB1 共享表位与 RA 放射学损伤之间的已知关联。先前验证的非 HLA 标记物缺乏复制突出了需要进一步研究以提供临床有用的遗传预后标记物。